Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02961413 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Prospective Cohort Study on Drug-induced Liver Injury in China（DILI-P）

Study acronym: DILI-P
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 2020 to Dec 2030v15
  2. Primary and study completion dates: Dec 2019 to Dec 2020v14
  3. 2 versions Re-verified since Aug 19, 2019, no change to tracked fieldsv12-v13
  4. Primary and study completion dates: Dec 2018 to Dec 2019v11
  5. Primary and study completion dates: Dec 2017 to Dec 2018v10
Show 8 earlier versionsHide 8 earlier versions
  1. 2 versions Re-verified since Aug 15, 2017, no change to tracked fieldsv8-v9
  2. Primary completion date: Apr 2017 to Dec 2017
    • Study completion date: Jul 2017 to Dec 2017
    v7
  3. 5 versions Re-verified since Dec 1, 2016, no change to tracked fieldsv2-v6
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a multi-center, prospective, non-interventional cohort study . Its primary objectives are: 1. assess DILI patients' clinical characteristics, disease progression and influencing factors in clinical practice; 2. learn about suspected drug caused DILI,rechallenging, liver biochemical abnormalities mode, etc.
Trial Details
NCT Number NCT02961413
Lead Sponsor Drug Induced Liver Disease Study Group
Conditions
(from sponsor)		 Drug-induced Liver Injury
Related terms Chemical and Drug Induced Liver Injury
Enrollment 10,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov